cetylpyridinium chloride anhydrous has been researched along with Lipodystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, DJ; Childs, BG; Durik, M; Jeganathan, KB; Khazaie, K; Miller, JD; Pezeshki, A; Saltness, RA; Sieben, CJ; van Deursen, JM; Verzosa, GC; Wijers, ME; Zhong, J | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Lipodystrophy
Article | Year |
---|---|
Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.
Topics: Adipocytes; Aging; Animals; Apoptosis; Cell Separation; Cell Transformation, Neoplastic; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Epithelial Cells; Female; Health; Kidney; Lipodystrophy; Longevity; Male; Mice; Myocardium; Organ Specificity; Stem Cells; Time Factors | 2016 |